While several studies demonstrated non-significant or borderline effects for myocardial infarction, stroke or cardiovascular death, pooling the data revealed significant reductions in MACE and all-cause mortality
Moreover, GLP-1RA reduced the risk of MACE by 14% in the overall diabetic population, with an apparent greater effect in patients with established CV disease (16% vs 6% reduction, respectively), although the lack of significant interaction between subgroups does not allow to separate them [12]
Erythromelalgia is a rare neurovascular pain disorder characterized by episodic erythema, increased skin temperature, and burning pain, often triggered by heat or exertion
How is GHK-Cu typically supplied for research
Effects of Intranasal Insulin on Cognition in Memory-Impaired Older Adults: Modulation by APOE Genotype
Sensitivity of patient outcomes to pharmacist interventions